NFKBIA and renal cell carcinoma: Subsequent to decreased TAK1 phosphorylation, the activation of IκB-α was steadily and significantly inhibited by NVP-BEZ235 and PP242 rather than Rapamycin in RCC cells (Figures 6C,F; Supplementary Figure S3B).